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LETTERS TO THE EDITOR 
Wolff-Parkinson-WLite at Risk 
and Propafenone 
we read wil gren, ,“wc,1 ,hc recen, a&le by hdmere, al. ,I, 0” 
Ihe ckclraphyriologc e*ects ofinlravcnous and oral propafenone t” 
pat,ents n”h wowParkinson-Wh”e ryndmme. Ollr previous expc- 
nwce. allho”gh ronRr”dng ,hc clinical ubrervationr of L”d”l.3 et 
al. (II. suggcnls that i”:rave”o”r and oral propafenane therapy 11.5 
10 2 mdkg and Iw IU 9w mgiday. rerpecrively) may indeed he rare 
and ei%cdrc in [he managcmenl of palicnlr with Wolff-Parkmso”~ 
WhilE rylldrome a, risk 0.3,. I” our published prclimin.ry experi- 
e”ce. si): padent* with Wolff-Parkinson-White syndrome be$re 
prapnfcnonc therapy had sy”c”pe or presyncop dunng a” episode 
0, alnsl hbnlla,,o”: Lhe m,“““sl pmerc”ed RR ,“lw”a,~ ranged 
from 140 to 2w mr. One “l Ihe SIX, a 28 year aId pregnan, worna”. 
had a documented e&de of sustained atrial fibrillation ranidlv 
degencrad”g 10 ve”lriFular fibrillalion and requiringexternal ca’% 
version. I” panicular. B very shon minimal pre-excited RR inlerval 
,140 mr1 and a wry rapid Yc”t”c”,a, relponle ‘3W,“+“, WCK 
observed before vemr~c~lar fibrillation occurred. Both i”trave”o”s 
and oral pmptJe”onc induced a si~“i6canr increase of Ihe minimal 
pre-excited RR interval dunng spo”!a”ea”s or induced alrial hbril- 
Iado” I” all pauenn (SO%). WC agree that. irrespecwe oflhe inidal 
refraclory penod of the accessory pathway (1.41. prop&none. in 
contrasl to orhcr a”uarrhy,hmic drug miry he of value for the 
treatme”: or mahgnanl arrhythmias that complicate WolC 
Parkinson-While ryndmme. 
Finally. ourchnical expeliencc with propafenone empharizes the 
and6blilia~ary axmn or the dlug. Atria, Rbrillrdon Wi16 “01 inducible 
in two df six palienls after propafenone: in one of them. before 
propafenone therapy. atrial lachyarrhylhmia delenorated 10 vent+ 
cular fibnllalio”. 
In co”d”s,o”. wr experience and that of Ludmer ct a,. indicate 
that eve” in patientr with Wolff-Parkinson-White syndrome rho are 
at nsk for wnlriculrr fibrillation. propafefenone may be considered a” 
akernative to amiodarone or a” attraclive aher”“tivc Lo surgical 
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I am surwsed that in their article a” coronary ve”““s retroinjec- 
do”. in which Meerma”” et al. (II refer to more than 40 anicles 
!r”me &,ise hack xn ,he yeon ,927. !qa? 8”d !!w,, !hr cnn!libo- 
do” of Blanco et al. (2) was not incbded. 
I believe that the latter phyacians were the@ Lo demonstrate 
experii rntally that the most efficient way to maintain Ihe heart 
adequaely oxyRe”ated de,,,g open hear, surgery ,in the absence of 
the “urns and cxtracorrow.l circulatio”~ war !hrou”b retrwxade 
p&ion by way of th; coronary sinus. At that lime (1956),“they 
were developinga direcl approach to the anrlic valve. Ifs”. 1 believe 
The purpose ol our anicle wils certainly not Lo review the lblerature 
a” retroperfusmn m a” cxhaurtivr manner. in 6x8. the first pioneer- 
tmg wrk done in this field by Pratt in 1898. Roberts in 1943 and Beck 
in 1948 was not mentioned in our article. not because of its lack of 
scnenwic or historic imporbance, or bolh. but becmuse of as lack of 
dircc! rc!wa”cc to our subject matter. We belicvc that the imp”na”t 
work of Blanco and awxiates doer not directly relale to the 
dvnamicr of comnsrv venous rctrooerfurio” llhe mamr focus ofaur 
a&e,. Works &Ii& hack to l9i7 through 1954 aid cited in our 
article have direct bearing on the mechanw” and dynamics of 
coronary circulati”“. whach is the major low* of our anicle. 
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